Atlas Trials

Sagimet Biosciences Inc.

9 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Sagimet Biosciences Inc.

RecordFirmDate
A Drug-Drug Interaction Study of Denifanstat and Resmetirom in Healthy Adult Participants (NCT07216313)Sagimet Biosciences Inc.2025-09-30
Phase 1 Study to Evaluate the Safety, Tolerability, PK, and PD of TVB-3567 in Healthy Participants With or Without Acne (NCT06989840)Sagimet Biosciences Inc.2025-06-03
A Phase 3 Study Evaluating the Safety and Efficacy of Denifanstat in Patients With MASLD and MASH (NCT06692283)Sagimet Biosciences Inc.2025-03-01
A Phase 3 Study Evaluating the Safety and Efficacy of Denifanstat in Patients With MASH and F2/F3 Fibrosis (NCT06594523)Sagimet Biosciences Inc.2025-03-01
A Phase I Pharmacokinetic Study of TVB-2640 (Denifanstat) in Subjects With Mild, Moderate, or Severe Hepatic Impairment Compared to Subjects With Normal Hepatic Function (NCT05835180)Sagimet Biosciences Inc.2023-05-01
Open-label Study of the Absorption, Metabolism, and Excretion of [14C]TVB-2640 Following a Single Oral Dose in Healthy Male Subjects (NCT05657834)Sagimet Biosciences Inc.2022-11-21
Study of TVB-2640 in Subjects With Nonalcoholic Steatohepatitis (NASH) (NCT04906421)Sagimet Biosciences Inc.2021-08-12
Study of TVB-2640 in Subjects With Non-Alcoholic Steatohepatitis (NASH) (NCT03938246)Sagimet Biosciences Inc.2019-03-22

Track Sagimet Biosciences Inc. automatically

Every clearance here is in the API, with alerts when new ones post.